Kirakosyan O, Reimann M, Andersen AB, Bjarnason A, Bakos Á, Dyrhol-Riise AM, McLaughlin AM, Nita C, Pieridou D, Chesov D, Davidavičienė EV, Günther G, Atshemyan H, Muylle I, Solovic I, Bruchfeld J, Manika K, Kuksa L, Codecasa LR, Stosic M, Skowroński M, Makek MJ, Fréchet Jachym M, Knappik M, Santin M et al. (2025)
Use of putative hepatoprotective agents as an adjunct to anti-TB treatment in Europe
IJTLD Open, 2 (2), 101-106
DOI 10.5588/ijtldopen.24.0498, PubMed 39959402

Pillay P, Galappaththi-Arachchige HN, Taylor M, Roald B, Kjetland EF (2025)
Urinary human papillomavirus DNA as an indicator of gynaecological infection in young women in Schistosoma and HIV endemic South Africa
Front Glob Womens Health, 5, 1436064
DOI 10.3389/fgwh.2024.1436064, PubMed 39916795

Viermyr HK, Tonby K, Ponzi E, Trouillet-Assant S, Poissy J, Arribas JR, Dyon-Tafani V, Bouscambert-Duchamp M, Assoumou L, Halvorsen B, Tekin NB, Diallo A, De Gastines L, Munthe LA, Murphy SL, Ueland T, Michelsen AE, Lund-Johansen F, Aukrust P, Mootien J, Dervieux B, Zerbib Y, Richard JC, Prével R, Malvy D et al. (2024)
Safety of baricitinib in vaccinated patients with severe and critical COVID-19 sub study of the randomised Bari-SolidAct trial
EBioMedicine, 111, 105511
DOI 10.1016/j.ebiom.2024.105511, PubMed 39731852